The Indian Competition Authority fines MRI manufacturer for abuse of dominance, with the Chairman dissenting due to different market definition that would conclude no dominance (House of Diagnostics / Esaote Asia Pacific)

CCI imposes penalty on Esaote SPA and its Indian subsidiary for abusing its dominant position in the sale of specialized MRI machines* The CCI vide its order dated September 27, 2018 has imposed a penalty of INR 9.33 lakhs on Esaote S.p.A and its Indian subsidiary, Esaote Asia Pacific Diagnostic Pvt. Ltd. (collectively ‘OPs’) for abusing its dominant position in the sale of “Dedicated Standing/ Tilting MRI machines” under the G-Scan brand name. The order was passed by a 2:1 majority with the dissent penned by the Chairman, Mr Sudhir Mital, who disagreed on the definition of relevant market

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Vaish Associates, Advocates (New Delhi)

Quotation

Man Mohan Sharma, The Indian Competition Authority fines MRI manufacturer for abuse of dominance, with the Chairman dissenting due to different market definition that would conclude no dominance (House of Diagnostics / Esaote Asia Pacific), 27 September 2018, e-Competitions Bulletin September 2018, Art. N° 89537

Visites 15

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues